Overview

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
Hypothesis - Infusional gemcitabine may give better intracellular pharmacologic activation and be more effective clinically in non-small cell lung cancer
Phase:
Phase 2
Details
Lead Sponsor:
National University Hospital, Singapore
Collaborator:
Eli Lilly and Company
Treatments:
Carboplatin
Gemcitabine